Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy.
Ther Adv Drug Saf
; 12: 2042098621991280, 2021.
Article
em En
| MEDLINE
| ID: mdl-33628419
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article